Department of Chemistry, College of Science, National Kaohsiung Normal University, Yanchao District, Kaohsiung City, Taiwan, ROC.
Bioorg Med Chem Lett. 2012 Mar 15;22(6):2326-9. doi: 10.1016/j.bmcl.2012.01.048. Epub 2012 Jan 26.
Two sesquiterpenoids, atractylenolide II and III, were isolated and identified from Atractylodes macrocephala (Asteraceae) to be subsequently evaluated for their activity against farnesoid X receptor (FXR) and progesterone receptor (PR) by transient transfection reporter assays. These sesquiterpenoids did not exert significant agonistic effect but antagonized the activity of chenodeoxycholic acid (CDCA), an endogenous FXR agonist, for FXR driven SHP promoter transactivation. Additionally, they transactivated CYP7A1 gene promoter activity by antagonizing FXR. Apart from acting as a FXR antagonist, atractylenolide III also showed agonistic activity against PR. All these results demonstrated that atractylenolide II and III are the active components of Atractylodes macrocephala to exert specific pharmacologic effects.
从白术(菊科)中分离得到两种倍半萜烯,即白术内酯 II 和 III,并通过瞬时转染报告基因检测评估其对法尼醇 X 受体(FXR)和孕激素受体(PR)的活性。这些倍半萜烯没有表现出显著的激动作用,但拮抗了内源性 FXR 激动剂鹅去氧胆酸(CDCA)对 FXR 驱动的 SHP 启动子转录激活的作用。此外,它们通过拮抗 FXR 来转激活 CYP7A1 基因启动子活性。除了作为 FXR 拮抗剂外,白术内酯 III 还对 PR 表现出激动活性。所有这些结果表明,白术内酯 II 和 III 是白术发挥特定药理作用的有效成分。